MedSpa Compliance: Understanding FDA Regulations

What changed: The Drug Supply Chain Security Act (DSCSA) is now being enforced at the medical practice level, impacting aesthetic treatments compliance. Any practice that purchases, stores, or administers drug products in-office is now subject to FDA enforcement for MedSpas, meaning compliance inspections will extend beyond manufacturers, wholesale distributors, and pharmacies.

The Drug Products at Issue in Med Spa & Aesthetics Practices

If your practice purchases and administers any of the following, federal drug supply chain requirements apply to you regardless of whether you operate a pharmacy:

Injectable & Aesthetic Treatments

• Neurotoxins (Botox, Dysport, Xeomin, Daxxify)

• Dermal fillers (Juvéderm, Restylane, Sculptra)

• Kybella (deoxycholic acid)

• Platelet-rich plasma (PRP) therapies

Specialty & Emerging Products

• Weight loss medications (GLP-1s: semaglutide, tirzepatide)

• Prescription-strength retinoids

• Prescription-strength hydroquinone

• Eyelash enhancers (Latisse / bimatoprost)

• Peptide therapies (Ipamorelin, BPC-157, Sermorelin)

Woman receiving multiple facial treatments simultaneously at a spa.

Medical spas are among the highest-risk practice types for DSCSA enforcement.

Med spas have become one of the first targets of expanded FDA enforcement for MedSpas. The use of neurotoxins, fillers, and biologic agents, which are often sourced through a mix of authorized and gray-market channels, creates significant traceability exposure and challenges in aesthetic treatments compliance. If an inspector walks in today, can you demonstrate a clean chain of custody for every vial of Botox?

A high reliance on neurotoxins and biologics, subject to strict serialization requirements, adds to the complexity. Frequent sourcing from gray markets creates gaps in authorized trading partnerships. Additionally, purchase-to-administration reconciliation is rarely maintained at the unit level. Notably, the FDA's first physician-practice 483 was issued to an aesthetics operation.

MedSpa Compliance: Understanding FDA Regulations

Medical spas are among the highest-risk practice types for DSCSA enforcement.

This website uses cookies.